Benzinga's Top Initiations

Morgan Stanley initiated coverage on Tribune Media Co (NYSE: TRCO) with a Equal-weight rating. The target price for Tribune Media is set to $45. Tribune Media shares closed at $43.59 yesterday.

Analysts at Imperial Capital initiated coverage on FleetMatics Group PLC (NYSE: FLTX) with a In-line rating. The target price for FleetMatics Group is set to $52. FleetMatics Group shares closed at $50.15 yesterday.

Analysts at Barclays initiated coverage on WEX Inc (NYSE: WEX) with a Equal-weight rating. The target price for WEX is set to $110. WEX shares closed at $98.50 yesterday.

Goldman Sachs initiated coverage on International Game Technology Ordinary Shares (NYSE: IGT) with a Sell rating. The target price for International Game Technology is set to $15.50. International Game Technology shares closed at $19.28 yesterday.

Analysts at Cowen & Company initiated coverage on Dermira Inc (NASDAQ: DERM) with a Outperform rating. The target price for Dermira is set to $40. Dermira shares closed at $24.76 yesterday.

Analysts at H.C. Wainwright initiated coverage on Gevo, Inc. (NASDAQ: GEVO) with a Buy rating. The target price for Gevo is set to $5. Gevo shares closed at $2.26 yesterday.

Analysts at Macquarie initiated coverage on Navistar International Corp (NYSE: NAV) with a Neutral rating. The target price for Navistar International is set to $19. Navistar International shares closed at $17.64 yesterday.

Analysts at H.C. Wainwright initiated coverage on Biocept Inc (NASDAQ: BIOC) with a Buy rating. The target price for Biocept is set to $4. Biocept shares closed at $1.96 yesterday.

Analysts at Maxim Group initiated coverage on Chipotle Mexican Grill, Inc. (NYSE: CMG) with a Hold rating. Chipotle Mexican Grill shares closed at $745.92 yesterday.

Analysts at Goldman Sachs initiated coverage on Scientific Games Corp (NASDAQ: SGMS) with a Sell rating. The target price for Scientific Games is set to $7.50. Scientific Games shares closed at $12.14 yesterday.

Posted-In: Top InitiationsInitiation Analyst Ratings

© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.